General Information of DME (ID: DEO1IE3)

DME Name Cytochrome P450 3A43 (CYP3A43) DME Info
Gene Name CYP3A43

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
5 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethosuximide DMDZ9LT Epilepsy 8A60-8A68 Approved [1]
Oxazepam DMXNZM4 Alcohol withdrawal delirium Approved [2]
Praziquantel DMOU1PK Flatworm infection 1F70-1F86 Approved [3]
Testosterone cypionate DMC1TEV N. A. N. A. Approved [4]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes. Xenobiotica. 2003 Mar;33(3):265-76.
2 Cytochrome P450 enzyme activity and protein expression in primary porcine enterocyte and hepatocyte cultures. Xenobiotica. 2000 Jan;30(1):27-46.
3 Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers. Clin Pharmacol Ther. 2002 Nov;72(5):505-13.
4 cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol. 2001 Feb;59(2):386-92.
5 Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet. 1997 Mar;32(3):194-209.